SCHEMBL13628670

SCHEMBL13628670

CC(C)NOC(CCc1ccccn1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.46
ALDH1A1 P00352 2/20 0.46
CYP2C19 P33261 1/20 0.46
HRH3 Q9Y5N1 1/20 0.44
LMNA P02545 2/20 0.43
TAAR1 Q96RJ0 1/20 0.43
ALOX15 P16050 1/20 0.43
GRIN2D O15399 1/20 0.42
GRIN3B O60391 1/20 0.42
GRIN1 Q05586 1/20 0.42
GRIN2A Q12879 1/20 0.42
GRIN2B Q13224 1/20 0.42
GRIN2C Q14957 1/20 0.42
GRIN3A Q8TCU5 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KDM4E B2RXH2 1/20 0.40
PLK1 P53350 1/20 0.40
HRH1 P35367 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13628672 0.76 CYP2D6 (0.55) CYP1A2ALDH1A1CYP2C19NPC1RAB9A
SCHEMBL14066327 0.74 GRIN2D (0.55) CYP1A2ALDH1A1CYP2C19HRH3LMNA
SCHEMBL13628956 0.74 CYP2D6 (0.37) CYP1A2ALDH1A1CYP2C19LMNAKDM4E
SCHEMBL30201139 0.72 CYP1A2 (0.61) CYP1A2ALDH1A1CYP2C19HRH3LMNA
SCHEMBL574013 0.72 CYP1A2 (0.61) CYP1A2ALDH1A1CYP2C19HRH3LMNA
SCHEMBL13628671 0.72 CYP1A2 (0.49) CYP1A2ALDH1A1CYP2C19HRH3LMNA
SCHEMBL19951056 0.70 ALDH1A1 (0.46) CYP1A2ALDH1A1CYP2C19HRH3LMNA
SCHEMBL10771160 0.70 HRH1 (0.57) CYP1A2ALDH1A1CYP2C19HRH3LMNA
SCHEMBL6938906 0.70 HRH1 (0.57) CYP1A2ALDH1A1CYP2C19HRH3LMNA
SCHEMBL8662285 0.70 CYP1A2 (0.53) CYP1A2ALDH1A1CYP2C19HRH3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612197-B2 Reacting a nucleophil with OH group with an electrophil to form an adduct, reacting adduct with a reagent selected from oxidizing, sulfurizing or selenizing agents to produce hydroxy protected oligonucleotide, heating to deprotect hydroxy protecting group such as 2-(2-pyridyl)aminoethoxycarbonyl The United States of America as repesented by the Secretary of the Department of Health and Human Services (US) 2009-11-03 US disclosed